Zhu, S., Quan, C. (2025). Adjuvant toripalimab in high-risk renal cell carcinoma after tumor resection (TUOAD-RCC): A prospective phase 2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16520